Topological analysis of treating vascular dementia with Reushen-Chuanxiong based on network pharmacology and molecular docking technology
Objective:To analyze the molecular mechanism of Renshen(Radix Ginseng)-Chuangxiong(Rhizoma Chuanxiong)in the treatment of vascular dementia(VD)based on network pharmacology and molecular docking technology topology,and to provide a basis for clinical application of Renshen-Chuanxiong.Methods:Firstly,the effective active components and targets ofRenshen-Chuanxiong were obtained by searching TCMSP database and related literature.The disease targets of VD were obtained through databases such as GeneCards.Using Weishengxin online platform,the intersection of Renshen-Chuanxiong and VD target was made by Wayne diagram.The protein interaction network model was constructed by STRING database,and the topology analysis was carried out by CytoScape 3.9.0 software.CytoScape 3.9.0 software was used to construct the component-target network diagram of Renshen-Chuanxiong and VD.DAVID database was used for GO analysis and KEGG pathway enrichment analysis.Finally,AutoDock Vina and other molecular docking software were used to verify the prediction results.Results:A total of 26 active components of Renshen-Chuanxiong were screened out,and 20 core targets such as SRC,PIK3R1,PIK3CA,PIK3CB and PIK3CD were screened out by topology analysis.KEGG analysis showed that the targets were mainly enriched in neuroactive ligand-receptor interaction,calcium signaling pathway,cAMP signaling pathway,cancer pathway and other signaling pathways.Finally,molecular docking technology was used to verify that the core target had good binding activity with the corresponding active components.Conclusion:Renshen-Chuanxiong compounds achieve the therapeutic effect on VD through multiple components,multiple targets,and multiple pathways,providing a research basis for the use of subsequent drug pairs in the treatment of VD.